Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 250

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Erythropoiesis-Stimulating Agents — Time for a Reevaluation

Unger, Ellis F., Thompson, Aliza M., Blank, Melanie J., Temple, Robert · 2010 · New England Journal of Medicine

Abstract

Epoetin alfa was approved in 1989 by the Food and Drug Administration (FDA) for the treatment of anemia associated with chronic kidney disease “to elevate or maintain the red blood cell level . . . and to decrease the need for transfusions.” Although epoetin alfa and darbepoetin alfa, a related erythropoiesis-stimulating agent (ESA) approved in 2001, have been widely accepted for this indication, optimal hemoglobin targets have never been established. A number of small studies conducted in the late 1980s supported the concept that higher hemoglobin concentrations are beneficial; the use of ESAs for anemia in patients with chronic kidney . . .

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1056/nejmp0912328

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 3 references

Cited by

See all 250

Metadata

Authors
Unger, E. F., Thompson, A. M., Blank, M. J., & Temple, R.
Venue
New England Journal of Medicine
Published
2010-01-21
Volume
362
Issue
3
Pages
189-192
ISSN
  • 0028-4793 (ISSN-L)
  • 1533-4406
OpenAlex
W2023245037
Cited by
250
References
3
FWCI
23.70
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Erythropoiesis-Stimulating Agents — Time for a Reevaluation. https://app.cochat.ai/papers/10.1056/nejmp0912328
The paper
Unger, E. F., Thompson, A. M., Blank, M. J., & Temple, R. (2010). Erythropoiesis-Stimulating Agents — Time for a Reevaluation. New England Journal of Medicine. https://doi.org/10.1056/nejmp0912328

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.